The Surveillance, Prevention, and Treatment of Viral Hepatitis: Looking Forward to Global Elimination

Dear Colleagues,

The Special Issue of Livers, entitled "The Surveillance, Prevention, and Treatment of Viral Hepatitis: Looking forward to Global Elimination" is scheduled to provide an in-depth exploration of the critical components necessary for diagnosing and effectively managing viral hepatitis. Moreover, it will be of great importance to include articles dealing with the global efforts and strategies aimed at preventing and eradicating viral hepatitis, which is recognized as a significant public health challenge.

Our aim is to encompass a wide range of topics, including the latest research findings on hepatitis viruses (A, B, C, D, and E), advancements in treatment options, and the implementation of effective public health policies to achieve the goal of viral hepatitis elimination.

The issue will try to highlight the importance of early diagnosis, vaccination, and access to antiviral therapies in the fight against hepatitis. Additionally, it addresses the socio-economic factors influencing hepatitis prevalence and explores innovative approaches to increase awareness and prevention efforts in vulnerable populations.

Overall, this Special Issue aims to serve as a comprehensive resource for healthcare professionals, researchers, and policymakers, providing insights into the multifaceted approach required to improve the surveillance, prevention, and treatment of viral hepatitis.

Dr. Melanie Deutsch
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Livers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.